ArticleNeuropsychiatric disease and treatment2025
Identification of Genes in Diagnosing Major Depressive Disorder with Anorexia Through Bioinformatics Analysis.
Article in Neuropsychiatric disease and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Researches have indicated that major depressive disorder (MDD) and anorexia may have overlapping pathogenic mechanisms. In light of this, we endeavored to identify diagnostic gene candidates for MDD in individuals with comorbid anorexia. Methods: Gene expression data pertaining to MDD and healthy controls (HC) were retrieved from the Gene Expression Omnibus (GEO) database. Utilizing Limma and weighted gene co-expression network analysis (WGCNA), key MDD-associated genes were meticulously screened. Subsequently, these genes were cross-referenced with established anorexia-related genes to pinpoint common genetic factors shared between MDD and anorexia. Further refinement was conducted using Cytoscape software to identify hub-genes. Ultimately, animal experiments were conducted to validate and confirm the findings. Results: We identified a total of 214 genes that are commonly associated with both MDD and anorexia. These genes were found to be enriched in inflammatory and immune-related pathways. Among these 214 genes, six were distinguished as hub-genes: IL10, ITGAM, PTPRC, IL13, STAT5B, and JAK2. Immune infiltration analysis further revealed that all these hub-genes exhibited associations with multiple immune cell types. Animal experiments demonstrated that, compared to control mice, the model group exhibited significantly elevated expression levels of PTPRC, STAT5B, and JAK2. Conclusion: Through the application of bioinformatics analysis and animal experimentation, we have pinpointed three hub-genes (PTPRC, STAT5B, and JAK2) that hold potential as both diagnostic biomarkers and therapeutic targets for MDD accompanied with anorexia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.